Filing Details
- Accession Number:
- 0001213900-24-008559
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-31 18:28:58
- Reporting Period:
- 2024-01-29
- Accepted Time:
- 2024-01-31 18:28:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1553643 | Relmada Therapeutics Inc. | RLMD | Pharmaceutical Preparations (2834) | 455401931 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1658369 | Maged Shenouda | C/O Relmada Therapeutics, Inc. 2222 Ponce De Leon Blvd, 3Rd Floor Coral Gables, FL 33134 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-01-29 | 10,800 | $3.65 | 13,028 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-01-30 | 15,000 | $3.89 | 28,028 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-01-31 | 6,875 | $4.06 | 34,903 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
- Purchase prices range from $3.57 to $3.745 per share, inclusive.
- Purchase prices range from $3.82 to $3.90 per share, inclusive.
- Purchase prices range from $3.95 to $4.18 per share, inclusive.